SlideShare a Scribd company logo
1 of 6
Download to read offline
RESEARCH ARTICLE Open Access
Who seeks primary care for musculoskeletal
disorders (MSDs) with physicians prescribing
homeopathic and other complementary
medicine? Results from the EPI3-LASER survey
in France
Michel Rossignol1*
, Bernard BĂ©gaud2
, Bernard Avouac3
, France Lert4
, Frédéric Rouillon5
, Jacques BĂ©nichou6
,
Jacques Massol7
, GĂ©rard Duru8
, Anne-Marie Magnier9
, Didier Guillemot10
, Lamiae Grimaldi-Bensouda11
,
Lucien Abenhaim12
Abstract
Background: There is a paucity of information describing patients with musculoskeletal disorders (MSDs) using
complementary and alternative medicines (CAMs) and almost none distinguishing homeopathy from other CAMs.
The objective of this study was to describe and compare patients with MSDs who consulted primary care
physicians, either certified homeopaths (Ho) or regular prescribers of CAMs in a mixed practice (Mx), to those
consulting physicians who strictly practice conventional medicine (CM), with regard to the severity of their MSD
expressed as chronicity, co-morbidity and quality of life (QOL).
Methods: The EPI3-LASER study was a nationwide observational survey of a representative sample of general
practitioners and their patients in France. The sampling strategy ensured a sufficient number of GPs in each of the
three groups to allow comparison of their patients. Patients completed a questionnaire on socio-demographics,
lifestyle and QOL using the Short Form 12 (SF-12) questionnaire. Chronicity of MSDs was defined as more than
twelve weeks duration of the current episode. Diagnoses and co-morbidities were recorded by the physician.
Results: A total of 825 GPs included 1,692 MSD patients (predominantly back pain and osteoarthritis) were
included, 21.6% in the CM group, 32.4% Ho and 45.9% Mx. Patients in the Ho group had more often a chronic
MSD (62.1%) than the CM (48.6%) or Mx (50.3%) groups, a result that was statistically significant after controlling for
patients’ characteristics (Odds ratio = 1.43; 95% confidence interval (CI): 1.07 - 1.89). Patients seen by homeopaths
or mixed practice physicians who were not the regular treating physician, had more often a chronic MSD than
those seen in conventional medicine (Odds ratios were1.75; 95% CI: 1.22 - 2.50 and 1.48; 95% CI: 1.06 - 2.12,
respectively). Otherwise patients in the three groups did not differ for co-morbidities and QOL.
Conclusion: MSD patients consulting primary care physicians who prescribed homeopathy and CAMs differed
from those seen in conventional medicine. Chronic MSD patients represented a greater proportion of the clientele
in physicians offering alternatives to conventional medicine. In addition, these physicians treated chronic patients
as consulting rather than regular treating physicians, with potentially important impacts upon professional health
care practices and organisation.
* Correspondence: Michel.Rossignol@CRR-Intl.com
1
Department of Epidemiology, Biostatistics and Occupational Health, McGill
University, Canada and LA-SER Centre for Risk Research, Montreal, Canada
Full list of author information is available at the end of the article
Rossignol et al. BMC Musculoskeletal Disorders 2011, 12:21
http://www.biomedcentral.com/1471-2474/12/21
© 2011 Rossignol et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Background
Physicians in primary care play a central role in the man-
agement of musculoskeletal disorders (MSDs). This
group of health problems also represents a leading reason
of recourse to complementary and alternative medicines
(CAM) including homeopathy. There is a paucity of
information describing MSD patients using CAMs and
almost none distinguishing homeopathy from other
forms of CAM. In France, homeopathy is the most fre-
quently used CAM and is prescribed only by physicians,
typically general practitioners (GP). In addition, homeop-
athy is reimbursed by the French National Health Insur-
ance which allowed a fair comparison of patients who
seek care with physicians who prescribe and don’t pre-
scribe homeopathy and CAMs. The objective of this
study was to describe and compare patients with MSDs
consulting primary care physicians, either certified
homeopaths (Ho) or regular prescribers of CAMS in a
mixed practice (Mx), to those consulting physicians who
practice strictly conventional medicine (CM), with regard
to the severity of their MSD expressed as chronicity,
co-morbidity and quality of life (QOL).
Methods
Study design and population
This analysis used data collected from the EPI3-LASER
nationwide observational survey of a representative sam-
ple of general practitioners and their patients, conducted
in France between March 2007 and July 2008. Its aims
were to assess the burden of disease in general practice,
considering physician and patients characteristics and
co-morbidities with a specific focus on health-related
QOL. Study subjects were drawn from a two-stage sam-
pling. First, general practitioners (GPs) were randomly
selected from the French national directory of physicians
and invited to participate. GPs sampling was stratified
according to their declaration of CAM utilisation cate-
gorised in three groups, strict conventional medicine
practitioners (CM) who declared themselves never or
rarely using homeopathy or CAMs, physicians declaring
using CAMs regularly in a mixed practice (Mx), and
registered homeopaths who are GPs specialised in
homeopathy (Ho). Physicians were classified in one of
those three categories after they had agreed to partici-
pate to the survey by answering a short telephone ques-
tionnaire designed to that effect. As physicians in all
three groups were certified professionals, their practice
was based on conventional medicine. The Ho group dif-
fered because the physicians were also certified homeo-
paths with a clear orientation toward this type of CAM.
The Mx group however could not be labelled specifically
as they only declared their use of CAMs but did not
indicate the type or any specific preferences.
Sampling of physicians continued until Mx and Ho
GPs were over-sampled compared to CM GPs with
ratios respectively of 2:1 and 3:2. This was done in
order to account for the variety of practices, especially
in the Mx group. The second stage of sampling con-
sisted of randomly selecting a one-day of consultation
for each participating physician to survey all patients
attending the practice on that specific day. All patients
were eligible for inclusion at the exception of those
whose health status or literacy level did not allow
responding to a self-administered questionnaire.
Data collection
Consenting patients completed a self-administered ques-
tionnaire that included information on age, sex, educa-
tion, employment status and occupation, hospitalisation
and medical visits in the previous twelve months, smok-
ing, alcohol intake, physical activity, height and weight,
and health related QOL assessed by the Short Form 12
(SF-12) questionnaire [1]. Patients were also asked to
declare if the physician consulted that day was their reg-
ular treating physician or not. In France all citizens are
required to identify a physician for their regular health
care. In this study, the physicians’ role was labelled
‘treating’ or ‘consulting’ based on patients’ responses.
GPs completed a medical questionnaire including the
main reason for consultation and up to five other diag-
noses present that day and for each, the duration of the
health problem in its current episode. GPs then
recorded their prescriptions that day for diagnostic tests,
drugs and referrals. Diagnoses were coded by a trained
archivist using the 9th
revision of the International Clas-
sification of Diseases.
for this analysis, adult patients 18 years and older
with a MSD as their main reason for consultation,
were selected from the general survey. MSDs included
spinal disorders (SD) with ICD codes 720 to 724,
osteoarthritis and tendonitis of the upper or lower
limb, with ICD codes 715, 719, 729, 726-728, 782.
Patients with a diagnosis of infectious, neoplastic or
specific inflammatory (such as rheumatoid arthritis or
Lupus) joint disease as their main reason for consulta-
tion were excluded from the analyses. MSDs were clas-
sified as non-chronic or chronic using a twelve-week
(three months) cut-off for duration of symptoms at
inclusion in accordance with consensus recommenda-
tions for research on MSDs [2]. Co-morbidity was
defined as the presence of at least one diagnosis other
than the principal reason of consultation at the recruit-
ment visit. Co-morbidities were categorised as MSD
(other than the main reason for consultation), cardio-
vascular or respiratory, anxiety or depressive disorders,
sleeping disorders and digestive.
Rossignol et al. BMC Musculoskeletal Disorders 2011, 12:21
http://www.biomedcentral.com/1471-2474/12/21
Page 2 of 6
Statistical analysis
Patient non-participation was accounted for by perform-
ing a calibration of the sample using the CALMAR pro-
cedure on all variables that were collected from all
eligible patients (sex, age, length of time attending the
GPs’ practice, type of health insurance and main reason
for consultation) [3]. Multiple logistic regression ana-
lyses were used to compare patients in the Ho and Mx
groups to the CM group for categorical variables and
adjusted for all variables in Table 1 and 2 for potential
confounding. Mean scores of the SF-12 mental and
physical scales were adjusted for sex, age and co-mor-
bidities using the analysis of covariance. All analyses
were performed using SAS version 9.1.
The study was approved by the French National Data-
Protection Commission (CNIL) and the French National
Council of Physicians (CNOM). Participating physicians
received compensation fees for recruiting but not
patients.
Results
Patients’ characteristics
Eight hundred and twenty five physicians agreed to par-
ticipate in the study. Their geographical distribution
covered the 22 regions of France. Their median age was
52 years, 20% were female, 52% worked in solo practice
and 78% practiced fee-for-service in addition to the gen-
eral health insurance regime which corresponds to
national statistics on medical manpower [4]. Of the
10,803 patients identified as potential participants, 2,151
(20%) declined participation and 93 were excluded
because of missing information leaving a final sample of
8,559, of whom 1,692 (20%) had a MSD. Characteristics
of patients by type of medical practice are shown in
Table 1. Patients in the Ho group were more often
older non-smoking females with higher education and a
lower body mass index than in the CM group. Patients
in the Mx group did not differ from those in the CM
group.
Type and severity of MSDs
Characteristics of MSDs by type of primary care practice
are shown in Table 2. The mix of spinal (low-back pain
and other back problems) and non-spinal MSDs was
similar between groups with spinal representing over
one third of the reasons for consultation.
The first indicator of severity of MSD, chronicity, was
more often observed in homeopathic practice, with
62.1% lasting for more than twelve weeks at the time of
the survey, versus 48.6% in the CM group, a difference
which was statistically significant in multivariate analysis
with an Odds ratio of 1.43 (95% confidence interval
(CI): 1.07 - 1.89). At the same time, homeopaths were
less often declared as the regular treating physician by
their patients with 54.1% compared with 84.0% in the
CM practice group. An interaction was observed
between chronicity of the MSD and not being the regu-
lar treating physician (consulting). An excess risk of
chronicity of 75% and 48% respectively was observed in
MSD patients in the Ho and Mx groups when the physi-
cian was a consultant compared to being the regular
treating physician (Odds ratios respectively 1.75, (95%
CI : 1.22 - 2.50 and 1.48, 95%CI: 1.06 - 2.12).
The second indicator of severity of MSD was the fre-
quency of co-morbidities (Table 3). Proportions of
Table 1 Socio-demographic characteristics of patients
consulting for a MSD in primary care (N = 1692)
Type of primary care provider
Conventional
medicine
Mixed Homeopathic
N = 366 N = 778 N = 548
Sex (% Females) 59.0 64.2 76.9*
Age categories
18-39 21.7 19.6 13.9*
40-59 35.8 39.2 37.3*
60 and over 42.4 41.2 48.8*
Employment status
(%) Employed 47.5 44.9 42.7
Unemployed 2.6 4.3 2.0
Home maker 2.9 5.1 3.2
Student 2.4 1.5 1.5
Retired 44.6 44.1 50.5
Educational level
(%) Secondary
school or more
39.4 35.4 45.9*
Familial status (%)
Living with a spouse 66.7 67.7 68.8
Living with children 36.8 40.3 36.4
Body Mass Index
<25 46.3 48.8 59.1*
25-30 36.9 32.8 31.1*
30 and over 16.8 18.5 9.6*
Tobacco consumption
(%) Non smoker 48.1 55.5 62.1*
Past smoker 25.7 24.1 23.1*
Current smoker 26.2 20.4 14.7*
Alcohol Consumption
(%)
Never 33.1 32.6 28.8
Sometimes 51.4 55.4 57.4
Daily 15.5 12.0 13.8
Physical exercise
(%) 0-30 minutes per
day
59.5 60.9 66.1
31 minutes and over 40.5 39.1 33.9
* Difference with conventional medicine category statistically significant
(p ≀ 0.05) in logistic regression including all variables.
Rossignol et al. BMC Musculoskeletal Disorders 2011, 12:21
http://www.biomedcentral.com/1471-2474/12/21
Page 3 of 6
patients with any type of co-morbidities were very simi-
lar between the three groups of patients. MSDs as sec-
ondary diagnoses (in addition the MSD main diagnosis)
were relatively frequent with 13.1% to 15.7% across the
three groups of patients. Similar proportions were
observed for anxiety and depressive disorders (12.5% to
14.6%). Sleeping and digestive disorders were less fre-
quent co-morbidities and did not show important differ-
ences between types of physicians’ practice.
Thirdly, severity of MSD was assessed with the SF-12
instrument, a standardised measure of QOL. The mean
scores adjusted for age, sex, co-morbidities and whether
the treating physician was the regular physician or not,
showed no difference between the types of practices, the
mental and physical SF-12 scores being almost identical
(Table 4). Comparisons between chronic and non-
chronic patients however showed lower SF-12 values
indicating poorer QOL in chronic patients in the CM or
Mx practice groups but not in the Ho group.
Discussion
This study is one of few providing comparative data on
use of homeopathy and other types of CAMs compared
to conventional primary care in a representative popula-
tion of patients. The results showed that patients who
consult for MSDs were comparable for quality of life
and co-morbidities regardless of the physicians’ prefer-
ences for prescribing homeopathy or CAMs. This corre-
sponds to what has been reported for physical QOL
score but not for mental score where patients using
CAMs have been found to have a slightly lower mental
scores [5-9]. Our study also showed that patients with
chronic MSDs tended to seek care more often with GPs
who prescribe alternatives to conventional medicine, a
finding that has been reported in other studies [10,11].
Socio-demographic and lifestyle differences between
MSD patients in the three groups of physicians could
have contributed in part to the results. For instance,
patients consulting homeopaths were more often older
and more educated women with less lifestyle risk factors
than those consulting in conventional primary care.
This corresponds to what has been described in other
studies of consultations in homeopathy in general
[12-15]. However, these factors were controlled for in
the analyses and the magnitude of the difference with
regard to chronicity was too high to be explained by
confounding factors alone.
We also found that these chronic MSD patients more
often declared their physician as not being their regular
treating physician. In France each citizen is required to
identify a physician for their regular health care. There-
fore, patients who did not declare their physician as
their regular physician, could be considered as consult-
ing in second intention, outside of their regular primary
care provider. The greater health care load assumed by
physicians who prescribe homeopathy and CAMs then
comes from two factors, greater proportions of chronic
patients and consultations in second intention. This
finding has significant bearing on professional practice
as almost half of the homeopath clientele in this study
was seen as a consultant. This information provided an
important complement to what has been reported on
the planning of homeopathic practice, particularly as it
differs from conventional medicine [16].
One strength of the study was that MSD patients were
identified from a larger survey of patients consulting for
Table 2 Characteristics of musculoskeletal disorders (MSD) in three types of primary care practice (N = 1,692)
Type of primary care practice
Conventional Medicine Mixed Homeopathic
(N = 366) (N = 778) (N = 548)
MSD site (%)
Spinal 37.7 41.2 35.9
Non-spinal 62.3 58.8 64.1
Chronicity (%)
>12 weeks 48.6 50.3 62.1
Physician role1
(%)
Treating 84.0 81.8 54.1
Consulting 16.0 18.2 45.9
Adjusted Odds ratios2
Risk of chronicity (vs. conventional medicine) 1
(–)
0.98
(0.77 - 1.26)
1.43
(1.07 - 1.89)
Risk of chronicity when Consulting (vs. Treating) 1.12
(0.63 - 1.99)
1.48
(1.06 - 2.12)
1.75
(1.22 - 2.50)
1. Role of the physician as declared by the patient; in France every citizen has to choose a physician as their regular treating physician (treating), physicians who
are not the regular treating physician are called here consulting physicians.
2. Logistic regression models controlling for all variables in Table 1 and 2.
Rossignol et al. BMC Musculoskeletal Disorders 2011, 12:21
http://www.biomedcentral.com/1471-2474/12/21
Page 4 of 6
any reason in primary care, thus minimising selection
bias related to sampling MSD patients directly. Another
strength was the specificity of the data collection for the
purposes of this study, combining medical information
on diagnoses and patients’ information on QOL, drugs
and CAMs utilisation, all collected on the day of con-
sultation, ensuring timely compatibility with diagnoses.
The large number of participating physicians and
patients favoured a fair representativity of clinical prac-
tices in primary care in France. A previous analysis of
the EPI3-LASER survey showed that the distribution of
physicians’ individual characteristics differed only
slightly from published French national statistics [4].
SF-12 scores observed in our patients were also not far
away from those reported in three European population
surveys of MSD patients, with score differences between
acute and chronic patients that were also similar
[17,18].
The main limitation of this study was the way the
three groups of physicians were defined, relying on their
own declaration of prescribing CAMs never or rarely
(CM) or regularly (Mx). The definition used for defining
the group of homeopaths (Ho) was more straightfor-
ward, being based on their professional certification.
These definitions potentially limit the generalisation of
the results as they represent the practice in France. On
the other hand, it also represents a strength because it
provided a unique opportunity to compare head-to-head
primary care practices differing only by preferences for
homeopathy and CAMs, all physicians shared similar
medical professional status and basic training in conven-
tional medicine. We feel that even if the context of the
study was specific to one country, differences between
the groups of patients may provide valid information on
the differential utilisation of homeopathy and CAMs,
meaningful beyond national borders.
Another important difference with studies performed
in other countries is that France is unique with Ger-
many to reimburse homeopathy in a national health
insurance regime. Therefore, access to this type of medi-
cal practice is specific and, unlike what has been
reported in the literature, less subjected to economic
barriers [13]. The best illustration of this came from our
observation of no apparent differences of access to
homeopathy and CAM by employment status. The eco-
nomic impacts of homeopathy and CAM on health care
deserve more attention in future research, particularly in
terms of the cost-benefit of complementary approaches
for chronic MSD patients who seek alternatives to con-
ventional medicine for the relief of their symptoms.
Table 3 Co-morbidities in patients with musculoskeletal disorders (MSD) in three types of primary care practice
(N = 1,692)
Type of primary care practice
Co-morbidities present at the medical visit Conventional Medicine Mixed Homeopathic
N = 366 N = 778 N = 548
At least one MSD co-morbidity (%) 13.8 13.1 15.7
At least one other co-morbidity (%) 72.7 73.3 74.4
Cardiovascular or respiratory conditions 29.9 31.6 28.1
Anxiety or depressive disorders 14.5 12.5 14.6
Sleeping disorders 4.3 3.5 4.6
Digestive disorders 8.0 6.7 8.1
Table 4 Quality of life in patients with musculoskeletal disorders (MSD) in three types of primary care practice
(N = 1,692)
Type of primary care practice
Conventional Medicine Mixed Homeopathic
All Acute1
Chronic1
All Acute Chronic All Acute Chronic
Quality of life SF-12
Mental score2
41.7 43.2* 40.0* 42.0 42.9* 41.1* 41.7 41.2 42.0
Mean (SD) (10.7) (9.5) (11.5) (10.3) (10.4) (10.1) (9.6) (9.3) (9.7)
Physical score2
42.4 43.4 41.3 41.9 43.1* 40.7* 42.8 43.6 42.3
Mean (SD) (10.4) (10.3) (10.4) (10.4) (10.9) (9.8) (10.8) (10.1) (11.2)
1 Chronicity defined as duration of the current MSD episode for more than 12 weeks.
2 Adjusted means in covariance analyses including age, sex, presence of co-morbidities and regular treating physician or not.
* Differences between acute and chronic patients statistically significant at p < 0.05.
Rossignol et al. BMC Musculoskeletal Disorders 2011, 12:21
http://www.biomedcentral.com/1471-2474/12/21
Page 5 of 6
Conclusion
MSD patients consulting a primary care physician who
prescribed homeopathy and CAMs differed from those
seen in conventional medicine. Accounting for the
socio-demographic and lifestyle differences, chronic
MSD patients represented a greater proportion of the
clientele in physicians offering alternatives to conven-
tional medicine. In addition, they treated chronic
patients as consulting rather than regular treating physi-
cians, with potentially important impacts upon profes-
sional health care practices and organisation.
Acknowledgements
The study was sponsored by an unrestricted funding from Laboratoires
Boiron, France to the members of LA-SER. Lamiae Bensouda-Grimaldi was
the recipient of a research fellowship from INSERM (French National Institute
of Health and Medical Research) at the time of the study. The authors wish
to thank Djamila Abed and RĂ©mi Sitta for their technical contribution in data
analyses.
Author details
1
Department of Epidemiology, Biostatistics and Occupational Health, McGill
University, Canada and LA-SER Centre for Risk Research, Montreal, Canada.
2
INSERM U657, Université Bordeaux2, Bordeaux, France. 3
LA-SER, Paris,
France. 4
INSERM, Centre for Epidemiology and Population Health, Villejuif,
France. 5
Centre Hospitalier Sainte-Anne, Université Paris V René Descartes,
Paris, France. 6
INSERM U657 Pharmacoepidemiology and evaluation of the
impact of health products on human health, France, and Department of
Biostatistics, University Hospital of Rouen, Rouen, France. 7
UFR de MĂ©decine,
Université de Franche Comté, Besançon, France. 8
CNRS (French National
Center for Scientific Research), Université Claude Bernard, Lyon, France.
9
Faculté de médecine Université Pierre et Marie Curie, Paris, France. 10
Institut
Pasteur and Université Paris-Ile de France Ouest, Paris, France. 11
Equipe
d’acceuil PharmacoĂ©pidĂ©miologie et maladies infectieuses, Institut Pasteur,
and LA-SER, Paris Cochin santé, France. 12
Department of Epidemiology,
London School of Hygiene & Tropical Medicine, London, U.K., and LA-SER,
London, U.K.
Authors’ contributions
All authors are members of the scientific committee that developed and
approved the study protocol and the analyses plan, discussed and
interpreted the results and revised the manuscript. MR, FL and LA drafted
the manuscript, LBG supervised all operational aspects of the study
including recruitments, data collection and management. MR supervised
data analyses. All authors have read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 16 August 2010 Accepted: 19 January 2011
Published: 19 January 2011
References
1. Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey:
construction of scales and preliminary tests of reliability and validity.
Med Care 1996, 34:220-233.
2. Dionne CE, Dunn KM, Croft PR, Nachemson AL, Buchbinder R, Walker BF,
Wyatt M, Cassidy JD, Rossignol M, Leboeuf-Yde C, Hartvigsen J, Leino-
Arjas P, Latza U, Reis S, Gil Del Real MT, Kovacs FM, Oberg B, Cedraschi C,
Bouter LM, Koes BW, Picavet HS, van Tulder MW, Burton K, Foster NE,
Macfarlane GJ, Thomas E, Underwood M, Waddell G, Shekelle P, Volinn E,
Von Korff M: A consensus approach toward the standardization of back
pain definitions for use in prevalence studies. Spine 2008, 33:95-103.
3. Deville JC, SĂ€rndal CE: Calibration estimation in survey sampling. J Am
Stat Assoc 1992, 87:375-382.
4. Institut de recherche et documentation en économie de la santé
(IRDES). Démographie des médecins Paris, France : IRDES; 2008.
5. Artus M, Croft P, Lewis M: The use of CAM and conventional treatments
among primary care consulters with chronic musculoskeletal pain. BMC
Fam Pract 2007, 8:26.
6. Chenot JF, Becker A, Leonhardt C, Keller S, Donner-Banzhoff N, Baum E,
Pfingsten M, Hildebrandt J, Basler HD, Kochen MM: Use of complementary
alternative medicine for low back pain consulting in general practice: a
cohort study. BMC Complement Altern Med 2007, 7:42.
7. Cizmesija T, Bergman-Marković B: [Use of complementary and alternative
medicine among the patients in primary health care]. Acta Med Croatica
2008, 62:15-22.
8. Herman CJ, Allen P, Hunt WC, Prasad A, Brady TJ: Use of complementary
therapies among primary care clinic patients with arthritis. Prev Chronic
Dis 2004, 1:A12.
9. Lind BK, Lafferty WE, Tyree PT, Sherman KJ, Deyo RA, Cherkin DC: The role
of alternative medical providers for the outpatient treatment of insured
patients with back pain. Spine 2005, 30:1454-1459.
10. Boon HS, Cherkin DC, Erro J, Sherman KJ, Milliman B, Booker J, Cramer EH,
Smith MJ, Deyo RA, Eisenberg DM: Practice patterns of naturopathic
physicians: results from a random survey of licensed practitioners in two
US States. BMC Complement Altern Med 2004, 4:14.
11. Steinsbekk A, Adams J, Sibbritt D, Jacobsen G, Johnsen R: The profiles of
adults who consult alternative health practitioners and/or general
practitioners. Scand J Prim Health Care 2007, 25:86-92.
12. Cherkin DC, Deyo RA, Sherman KJ, Hart LG, Street JH, Hrbek A, Davis RB,
Cramer E, Milliman B, Booker J, Mootz R, Barassi J, Kahn JR, Kaptchuk TJ,
Eisenberg DM: Characteristics of visits to licensed acupuncturists,
chiropractors, massage therapists, and naturopathic physicians. J Am
Board Fam Pract 2002, 15:463-472.
13. Fleming S, Rabago DP, Mundt MP, Fleming MF: CAM therapies among
primary care patients using opioid therapy for chronic pain. BMC
Complement. Altern Med 2007, 7:15.
14. Herman CJ, Dente JM, Allen P, Hunt WC: Ethnic differences in the use of
complementary and alternative therapies among adults with
osteoarthritis. Prev Chronic Dis 2006, 3:A80.
15. Kikuchi M, Matsuura K, Matsumoto Y, Inagaki T, Ueda R: Bibliographical
investigation of complementary alternative medicines for osteoarthritis
and rheumatoid arthritis. Geriatr Gerontol Int 2009, 9:29-40.
16. Thompson EA, Mathie RT, Baitson ES, Barron SJ, Berkovitz SR, Brands M,
Fisher P, Kirby TM, Leckridge RW, Mercer SW, Nielsen HJ, Ratsey DH,
Reilly D, Roniger H, Whitmarsh TE: Towards standard setting for patient-
reported outcomes in the NHS homeopathic hospitals. Homeopathy 2008,
97:114-121.
17. Kadam UT, Schellevis FG, Lewis M, van der Windt DA, de Vet HC,
Bouter LM, Croft PR: Does age modify the relationship between
morbidity severity and physical health in English and Dutch family
practice populations? Qual Life Res 2009, 18:209-220.
18. Loza E, Jover JA, Rodriguez L, Carmona L, EPISER Study Group:
Multimorbidity: prevalence, effect on quality of life and daily functioning,
and variation of this effect when one condition is a rheumatic disease.
Semin Arthritis Rheum 2009, 38:312-319.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2474/12/21/prepub
doi:10.1186/1471-2474-12-21
Cite this article as: Rossignol et al.: Who seeks primary care for
musculoskeletal disorders (MSDs) with physicians prescribing
homeopathic and other complementary medicine? Results from the
EPI3-LASER survey in France. BMC Musculoskeletal Disorders 2011 12:21.
Rossignol et al. BMC Musculoskeletal Disorders 2011, 12:21
http://www.biomedcentral.com/1471-2474/12/21
Page 6 of 6

More Related Content

What's hot

Medical Research Pharmacy
Medical Research PharmacyMedical Research Pharmacy
Medical Research PharmacyAparna Yadav
 
01 study design
01 study design01 study design
01 study designAnisur Rahman
 
Ethical aspects of anesthesia care and euthanasia
Ethical aspects of anesthesia care and euthanasiaEthical aspects of anesthesia care and euthanasia
Ethical aspects of anesthesia care and euthanasiaDr. Ravikiran H M Gowda
 
Effect of Behavioral Intervention on Reducing Symptom Severity during First C...
Effect of Behavioral Intervention on Reducing Symptom Severity during First C...Effect of Behavioral Intervention on Reducing Symptom Severity during First C...
Effect of Behavioral Intervention on Reducing Symptom Severity during First C...iosrjce
 
Assessing Adherence to Treatment: A Partnership
Assessing Adherence to Treatment: A PartnershipAssessing Adherence to Treatment: A Partnership
Assessing Adherence to Treatment: A Partnershipicapclinical
 
Gastroenterology Research and Practice Jan16
Gastroenterology Research and Practice Jan16Gastroenterology Research and Practice Jan16
Gastroenterology Research and Practice Jan16Lenka Kellermann
 
Determine the Patients' Satisfaction Concerning In-hospital Information Progr...
Determine the Patients' Satisfaction Concerning In-hospital Information Progr...Determine the Patients' Satisfaction Concerning In-hospital Information Progr...
Determine the Patients' Satisfaction Concerning In-hospital Information Progr...iosrjce
 
protocol ppt
protocol pptprotocol ppt
protocol pptjaveed baig
 
Eular recomendasi ra
Eular recomendasi   raEular recomendasi   ra
Eular recomendasi rakresnasuryana1
 
Clinical trials and evidence
Clinical trials and evidenceClinical trials and evidence
Clinical trials and evidencePratik patil
 
JOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATIONJOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATIONpankaj rana
 

What's hot (18)

Medical Research Pharmacy
Medical Research PharmacyMedical Research Pharmacy
Medical Research Pharmacy
 
01 study design
01 study design01 study design
01 study design
 
Ethical aspects of anesthesia care and euthanasia
Ethical aspects of anesthesia care and euthanasiaEthical aspects of anesthesia care and euthanasia
Ethical aspects of anesthesia care and euthanasia
 
Concept f risk
Concept f riskConcept f risk
Concept f risk
 
Costs of ADRs
Costs of ADRsCosts of ADRs
Costs of ADRs
 
10.1007_s11096-016-0258-9
10.1007_s11096-016-0258-910.1007_s11096-016-0258-9
10.1007_s11096-016-0258-9
 
Effect of Behavioral Intervention on Reducing Symptom Severity during First C...
Effect of Behavioral Intervention on Reducing Symptom Severity during First C...Effect of Behavioral Intervention on Reducing Symptom Severity during First C...
Effect of Behavioral Intervention on Reducing Symptom Severity during First C...
 
Cohort study 123 5 sushil
Cohort study 123 5 sushilCohort study 123 5 sushil
Cohort study 123 5 sushil
 
Assessing Adherence to Treatment: A Partnership
Assessing Adherence to Treatment: A PartnershipAssessing Adherence to Treatment: A Partnership
Assessing Adherence to Treatment: A Partnership
 
Gastroenterology Research and Practice Jan16
Gastroenterology Research and Practice Jan16Gastroenterology Research and Practice Jan16
Gastroenterology Research and Practice Jan16
 
Determine the Patients' Satisfaction Concerning In-hospital Information Progr...
Determine the Patients' Satisfaction Concerning In-hospital Information Progr...Determine the Patients' Satisfaction Concerning In-hospital Information Progr...
Determine the Patients' Satisfaction Concerning In-hospital Information Progr...
 
protocol ppt
protocol pptprotocol ppt
protocol ppt
 
Eular recomendasi ra
Eular recomendasi   raEular recomendasi   ra
Eular recomendasi ra
 
Pharmacogenomic presentation medication saftey 110417 final2
Pharmacogenomic presentation  medication saftey 110417 final2Pharmacogenomic presentation  medication saftey 110417 final2
Pharmacogenomic presentation medication saftey 110417 final2
 
Clinical trials and evidence
Clinical trials and evidenceClinical trials and evidence
Clinical trials and evidence
 
Cohort Study
Cohort StudyCohort Study
Cohort Study
 
cohort study
 cohort study cohort study
cohort study
 
JOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATIONJOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATION
 

Similar to Who seeks primary care for musculoskeletal disorders (MSDs) with physicians prescribing homeopathic and other complementary medicine? Results from the EPI3-LASER survey in France

Diagnoses and visit length in complementary and mainstream medicine
Diagnoses and visit length in complementary and mainstream medicineDiagnoses and visit length in complementary and mainstream medicine
Diagnoses and visit length in complementary and mainstream medicinehome
 
Modeling Opioid Risk
Modeling Opioid RiskModeling Opioid Risk
Modeling Opioid RiskPaul Coelho, MD
 
Homeopathic treatment of elderly patients - a prospective observational study...
Homeopathic treatment of elderly patients - a prospective observational study...Homeopathic treatment of elderly patients - a prospective observational study...
Homeopathic treatment of elderly patients - a prospective observational study...home
 
JOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATIONJOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATIONKAVIYA AP
 
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...Canadian Organization for Rare Disorders
 
A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...SriramNagarajan16
 
2016 EULAR FMS Guidelines
2016 EULAR FMS Guidelines2016 EULAR FMS Guidelines
2016 EULAR FMS GuidelinesPaul Coelho, MD
 
2016 EULAR FMS Guidelines
2016 EULAR FMS Guidelines2016 EULAR FMS Guidelines
2016 EULAR FMS GuidelinesPaul Coelho, MD
 
Policy recommendations for improved medication adherence in Europe: the ABC P...
Policy recommendations for improved medication adherence in Europe: the ABC P...Policy recommendations for improved medication adherence in Europe: the ABC P...
Policy recommendations for improved medication adherence in Europe: the ABC P...Global Risk Forum GRFDavos
 
Study of medication appropriateness during hospital stay and revisits in medi...
Study of medication appropriateness during hospital stay and revisits in medi...Study of medication appropriateness during hospital stay and revisits in medi...
Study of medication appropriateness during hospital stay and revisits in medi...iosrjce
 
Clinical Pharmacists in Chronic Care
Clinical Pharmacists in Chronic CareClinical Pharmacists in Chronic Care
Clinical Pharmacists in Chronic Caresubmissionclinmedima
 
introductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdfintroductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdfOgunsina1
 
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxINTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxAmeena Kadar
 
Evidence based practice for managing hypertension solution.edited
Evidence based practice for managing hypertension solution.editedEvidence based practice for managing hypertension solution.edited
Evidence based practice for managing hypertension solution.editedIsaiah Ogutu
 
Rebecca Ruggear Senior Thesis 2013
Rebecca Ruggear Senior Thesis 2013Rebecca Ruggear Senior Thesis 2013
Rebecca Ruggear Senior Thesis 2013Rebecca Ruggear
 
INSPIRE study BMC 2006
INSPIRE study BMC 2006INSPIRE study BMC 2006
INSPIRE study BMC 2006Sunil Ramkali
 
Original ArticleDesign and implementation of a randomized.docx
Original ArticleDesign and implementation of a randomized.docxOriginal ArticleDesign and implementation of a randomized.docx
Original ArticleDesign and implementation of a randomized.docxgerardkortney
 
Preliminary study of Prescription audit for evaluation of prescribing pattern...
Preliminary study of Prescription audit for evaluation of prescribing pattern...Preliminary study of Prescription audit for evaluation of prescribing pattern...
Preliminary study of Prescription audit for evaluation of prescribing pattern...SriramNagarajan16
 
Utilising the 7-step Polypharmacy Tool to Guide a Multi-Disciplinary Team Mee...
Utilising the 7-step Polypharmacy Tool to Guide a Multi-Disciplinary Team Mee...Utilising the 7-step Polypharmacy Tool to Guide a Multi-Disciplinary Team Mee...
Utilising the 7-step Polypharmacy Tool to Guide a Multi-Disciplinary Team Mee...Health Innovation Wessex
 

Similar to Who seeks primary care for musculoskeletal disorders (MSDs) with physicians prescribing homeopathic and other complementary medicine? Results from the EPI3-LASER survey in France (20)

Diagnoses and visit length in complementary and mainstream medicine
Diagnoses and visit length in complementary and mainstream medicineDiagnoses and visit length in complementary and mainstream medicine
Diagnoses and visit length in complementary and mainstream medicine
 
Modeling Opioid Risk
Modeling Opioid RiskModeling Opioid Risk
Modeling Opioid Risk
 
Homeopathic treatment of elderly patients - a prospective observational study...
Homeopathic treatment of elderly patients - a prospective observational study...Homeopathic treatment of elderly patients - a prospective observational study...
Homeopathic treatment of elderly patients - a prospective observational study...
 
JOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATIONJOURNAL CLUB PRESENTATION
JOURNAL CLUB PRESENTATION
 
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
 
A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...
 
2016 EULAR FMS Guidelines
2016 EULAR FMS Guidelines2016 EULAR FMS Guidelines
2016 EULAR FMS Guidelines
 
2016 EULAR FMS Guidelines
2016 EULAR FMS Guidelines2016 EULAR FMS Guidelines
2016 EULAR FMS Guidelines
 
Policy recommendations for improved medication adherence in Europe: the ABC P...
Policy recommendations for improved medication adherence in Europe: the ABC P...Policy recommendations for improved medication adherence in Europe: the ABC P...
Policy recommendations for improved medication adherence in Europe: the ABC P...
 
Study of medication appropriateness during hospital stay and revisits in medi...
Study of medication appropriateness during hospital stay and revisits in medi...Study of medication appropriateness during hospital stay and revisits in medi...
Study of medication appropriateness during hospital stay and revisits in medi...
 
Physician Dispensing
Physician DispensingPhysician Dispensing
Physician Dispensing
 
Clinical Pharmacists in Chronic Care
Clinical Pharmacists in Chronic CareClinical Pharmacists in Chronic Care
Clinical Pharmacists in Chronic Care
 
introductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdfintroductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdf
 
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptxINTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
INTRODUCTION TO PHARMACOEPIDEMIOLOGY.pptx
 
Evidence based practice for managing hypertension solution.edited
Evidence based practice for managing hypertension solution.editedEvidence based practice for managing hypertension solution.edited
Evidence based practice for managing hypertension solution.edited
 
Rebecca Ruggear Senior Thesis 2013
Rebecca Ruggear Senior Thesis 2013Rebecca Ruggear Senior Thesis 2013
Rebecca Ruggear Senior Thesis 2013
 
INSPIRE study BMC 2006
INSPIRE study BMC 2006INSPIRE study BMC 2006
INSPIRE study BMC 2006
 
Original ArticleDesign and implementation of a randomized.docx
Original ArticleDesign and implementation of a randomized.docxOriginal ArticleDesign and implementation of a randomized.docx
Original ArticleDesign and implementation of a randomized.docx
 
Preliminary study of Prescription audit for evaluation of prescribing pattern...
Preliminary study of Prescription audit for evaluation of prescribing pattern...Preliminary study of Prescription audit for evaluation of prescribing pattern...
Preliminary study of Prescription audit for evaluation of prescribing pattern...
 
Utilising the 7-step Polypharmacy Tool to Guide a Multi-Disciplinary Team Mee...
Utilising the 7-step Polypharmacy Tool to Guide a Multi-Disciplinary Team Mee...Utilising the 7-step Polypharmacy Tool to Guide a Multi-Disciplinary Team Mee...
Utilising the 7-step Polypharmacy Tool to Guide a Multi-Disciplinary Team Mee...
 

More from home

Homeopathy
HomeopathyHomeopathy
Homeopathyhome
 
Homeopathy—quackery or a key to the future of medicine?
Homeopathy—quackery or a key to the future of medicine?Homeopathy—quackery or a key to the future of medicine?
Homeopathy—quackery or a key to the future of medicine?home
 
Homeopathy in the treatment of fibromyalgia A comprehensive literature-review...
Homeopathy in the treatment of fibromyalgia A comprehensive literature-review...Homeopathy in the treatment of fibromyalgia A comprehensive literature-review...
Homeopathy in the treatment of fibromyalgia A comprehensive literature-review...home
 
Homeopathy as replacement to antibiotics in the case of Escherichia coli diar...
Homeopathy as replacement to antibiotics in the case of Escherichia coli diar...Homeopathy as replacement to antibiotics in the case of Escherichia coli diar...
Homeopathy as replacement to antibiotics in the case of Escherichia coli diar...home
 
Homeopathy and antimicrobial resistance
Homeopathy and antimicrobial resistanceHomeopathy and antimicrobial resistance
Homeopathy and antimicrobial resistancehome
 
articleHealth professionals’ and families’ understanding of the role ofindivi...
articleHealth professionals’ and families’ understanding of the role ofindivi...articleHealth professionals’ and families’ understanding of the role ofindivi...
articleHealth professionals’ and families’ understanding of the role ofindivi...home
 
Harm in homeopathy: Aggravations, adverse drug events or medication errors?
Harm in homeopathy: Aggravations, adverse drug events or medication errors?Harm in homeopathy: Aggravations, adverse drug events or medication errors?
Harm in homeopathy: Aggravations, adverse drug events or medication errors?home
 
Cutting Edge Research in Homeopathy: HRI’s second international research conf...
Cutting Edge Research in Homeopathy: HRI’s second international research conf...Cutting Edge Research in Homeopathy: HRI’s second international research conf...
Cutting Edge Research in Homeopathy: HRI’s second international research conf...home
 
CORE-Hom: A powerful and exhaustive database of clinical trials in homeopathy
CORE-Hom: A powerful and exhaustive database of clinical trials in homeopathyCORE-Hom: A powerful and exhaustive database of clinical trials in homeopathy
CORE-Hom: A powerful and exhaustive database of clinical trials in homeopathyhome
 
Controlled clinical studies of homeopathy
Controlled clinical studies of homeopathyControlled clinical studies of homeopathy
Controlled clinical studies of homeopathyhome
 
Clinical trial of homeopathy in rheumatoid arthritis
Clinical trial of homeopathy in rheumatoid arthritisClinical trial of homeopathy in rheumatoid arthritis
Clinical trial of homeopathy in rheumatoid arthritishome
 
Blisters and homeopathy: case reports and differential diagnosis
Blisters and homeopathy: case reports and differential diagnosisBlisters and homeopathy: case reports and differential diagnosis
Blisters and homeopathy: case reports and differential diagnosishome
 
A short history of the development of homeopathy in India
A short history of the development of homeopathy in IndiaA short history of the development of homeopathy in India
A short history of the development of homeopathy in Indiahome
 
Utilization of complementary and alternative medicine (CAM) among children fr...
Utilization of complementary and alternative medicine (CAM) among children fr...Utilization of complementary and alternative medicine (CAM) among children fr...
Utilization of complementary and alternative medicine (CAM) among children fr...home
 
Complementary medical health services: a cross sectional descriptive analysis...
Complementary medical health services: a cross sectional descriptive analysis...Complementary medical health services: a cross sectional descriptive analysis...
Complementary medical health services: a cross sectional descriptive analysis...home
 
Prayer-for-health and complementary alternative medicine use among Malaysian ...
Prayer-for-health and complementary alternative medicine use among Malaysian ...Prayer-for-health and complementary alternative medicine use among Malaysian ...
Prayer-for-health and complementary alternative medicine use among Malaysian ...home
 
Extreme sensitivity of gene expression in human SH-SY5Y neurocytes to ultra-l...
Extreme sensitivity of gene expression in human SH-SY5Y neurocytes to ultra-l...Extreme sensitivity of gene expression in human SH-SY5Y neurocytes to ultra-l...
Extreme sensitivity of gene expression in human SH-SY5Y neurocytes to ultra-l...home
 
Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner ...
Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner ...Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner ...
Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner ...home
 
P05.39. Clinical experiences of homeopaths participating in a study of the ho...
P05.39. Clinical experiences of homeopaths participating in a study of the ho...P05.39. Clinical experiences of homeopaths participating in a study of the ho...
P05.39. Clinical experiences of homeopaths participating in a study of the ho...home
 
P04.71. Acupuncture, self-care homeopathy, and practitioner-based homeopathy:...
P04.71. Acupuncture, self-care homeopathy, and practitioner-based homeopathy:...P04.71. Acupuncture, self-care homeopathy, and practitioner-based homeopathy:...
P04.71. Acupuncture, self-care homeopathy, and practitioner-based homeopathy:...home
 

More from home (20)

Homeopathy
HomeopathyHomeopathy
Homeopathy
 
Homeopathy—quackery or a key to the future of medicine?
Homeopathy—quackery or a key to the future of medicine?Homeopathy—quackery or a key to the future of medicine?
Homeopathy—quackery or a key to the future of medicine?
 
Homeopathy in the treatment of fibromyalgia A comprehensive literature-review...
Homeopathy in the treatment of fibromyalgia A comprehensive literature-review...Homeopathy in the treatment of fibromyalgia A comprehensive literature-review...
Homeopathy in the treatment of fibromyalgia A comprehensive literature-review...
 
Homeopathy as replacement to antibiotics in the case of Escherichia coli diar...
Homeopathy as replacement to antibiotics in the case of Escherichia coli diar...Homeopathy as replacement to antibiotics in the case of Escherichia coli diar...
Homeopathy as replacement to antibiotics in the case of Escherichia coli diar...
 
Homeopathy and antimicrobial resistance
Homeopathy and antimicrobial resistanceHomeopathy and antimicrobial resistance
Homeopathy and antimicrobial resistance
 
articleHealth professionals’ and families’ understanding of the role ofindivi...
articleHealth professionals’ and families’ understanding of the role ofindivi...articleHealth professionals’ and families’ understanding of the role ofindivi...
articleHealth professionals’ and families’ understanding of the role ofindivi...
 
Harm in homeopathy: Aggravations, adverse drug events or medication errors?
Harm in homeopathy: Aggravations, adverse drug events or medication errors?Harm in homeopathy: Aggravations, adverse drug events or medication errors?
Harm in homeopathy: Aggravations, adverse drug events or medication errors?
 
Cutting Edge Research in Homeopathy: HRI’s second international research conf...
Cutting Edge Research in Homeopathy: HRI’s second international research conf...Cutting Edge Research in Homeopathy: HRI’s second international research conf...
Cutting Edge Research in Homeopathy: HRI’s second international research conf...
 
CORE-Hom: A powerful and exhaustive database of clinical trials in homeopathy
CORE-Hom: A powerful and exhaustive database of clinical trials in homeopathyCORE-Hom: A powerful and exhaustive database of clinical trials in homeopathy
CORE-Hom: A powerful and exhaustive database of clinical trials in homeopathy
 
Controlled clinical studies of homeopathy
Controlled clinical studies of homeopathyControlled clinical studies of homeopathy
Controlled clinical studies of homeopathy
 
Clinical trial of homeopathy in rheumatoid arthritis
Clinical trial of homeopathy in rheumatoid arthritisClinical trial of homeopathy in rheumatoid arthritis
Clinical trial of homeopathy in rheumatoid arthritis
 
Blisters and homeopathy: case reports and differential diagnosis
Blisters and homeopathy: case reports and differential diagnosisBlisters and homeopathy: case reports and differential diagnosis
Blisters and homeopathy: case reports and differential diagnosis
 
A short history of the development of homeopathy in India
A short history of the development of homeopathy in IndiaA short history of the development of homeopathy in India
A short history of the development of homeopathy in India
 
Utilization of complementary and alternative medicine (CAM) among children fr...
Utilization of complementary and alternative medicine (CAM) among children fr...Utilization of complementary and alternative medicine (CAM) among children fr...
Utilization of complementary and alternative medicine (CAM) among children fr...
 
Complementary medical health services: a cross sectional descriptive analysis...
Complementary medical health services: a cross sectional descriptive analysis...Complementary medical health services: a cross sectional descriptive analysis...
Complementary medical health services: a cross sectional descriptive analysis...
 
Prayer-for-health and complementary alternative medicine use among Malaysian ...
Prayer-for-health and complementary alternative medicine use among Malaysian ...Prayer-for-health and complementary alternative medicine use among Malaysian ...
Prayer-for-health and complementary alternative medicine use among Malaysian ...
 
Extreme sensitivity of gene expression in human SH-SY5Y neurocytes to ultra-l...
Extreme sensitivity of gene expression in human SH-SY5Y neurocytes to ultra-l...Extreme sensitivity of gene expression in human SH-SY5Y neurocytes to ultra-l...
Extreme sensitivity of gene expression in human SH-SY5Y neurocytes to ultra-l...
 
Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner ...
Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner ...Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner ...
Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner ...
 
P05.39. Clinical experiences of homeopaths participating in a study of the ho...
P05.39. Clinical experiences of homeopaths participating in a study of the ho...P05.39. Clinical experiences of homeopaths participating in a study of the ho...
P05.39. Clinical experiences of homeopaths participating in a study of the ho...
 
P04.71. Acupuncture, self-care homeopathy, and practitioner-based homeopathy:...
P04.71. Acupuncture, self-care homeopathy, and practitioner-based homeopathy:...P04.71. Acupuncture, self-care homeopathy, and practitioner-based homeopathy:...
P04.71. Acupuncture, self-care homeopathy, and practitioner-based homeopathy:...
 

Recently uploaded

Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...hotbabesbook
 
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...narwatsonia7
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escortsvidya singh
 
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...narwatsonia7
 
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...Taniya Sharma
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...Neha Kaur
 
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...indiancallgirl4rent
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...jageshsingh5554
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escortsaditipandeya
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
High Profile Call Girls Coimbatore Saanvi☎ 8250192130 Independent Escort Se...
High Profile Call Girls Coimbatore Saanvi☎  8250192130 Independent Escort Se...High Profile Call Girls Coimbatore Saanvi☎  8250192130 Independent Escort Se...
High Profile Call Girls Coimbatore Saanvi☎ 8250192130 Independent Escort Se...narwatsonia7
 
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls ServiceKesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Servicemakika9823
 
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...astropune
 
Chandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD availableChandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD availableDipal Arora
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...narwatsonia7
 
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual NeedsBangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual NeedsGfnyt
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...Garima Khatri
 
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 âŁïžđŸ’Ż Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 âŁïžđŸ’Ż Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 âŁïžđŸ’Ż Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 âŁïžđŸ’Ż Top Class Girls AvailableNehru place Escorts
 

Recently uploaded (20)

Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
 
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
 
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
Top Rated Bangalore Call Girls Mg Road ⟟ 8250192130 ⟟ Call Me For Genuine Sex...
 
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
 
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Nagpur Just Call 9907093804 Top Class Call Girl Service Available
 
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
VIP Russian Call Girls in Varanasi Samaira 8250192130 Independent Escort Serv...
 
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
 
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Cuttack Just Call 9907093804 Top Class Call Girl Service Available
 
High Profile Call Girls Coimbatore Saanvi☎ 8250192130 Independent Escort Se...
High Profile Call Girls Coimbatore Saanvi☎  8250192130 Independent Escort Se...High Profile Call Girls Coimbatore Saanvi☎  8250192130 Independent Escort Se...
High Profile Call Girls Coimbatore Saanvi☎ 8250192130 Independent Escort Se...
 
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls ServiceKesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
 
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
 
Chandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD availableChandrapur Call girls 8617370543 Provides all area service COD available
Chandrapur Call girls 8617370543 Provides all area service COD available
 
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 7001035870  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 7001035870 Meetin With Bangalore Esc...
 
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual NeedsBangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
Bangalore Call Girl Whatsapp Number 100% Complete Your Sexual Needs
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
 
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 âŁïžđŸ’Ż Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 âŁïžđŸ’Ż Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 âŁïžđŸ’Ż Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 âŁïžđŸ’Ż Top Class Girls Available
 

Who seeks primary care for musculoskeletal disorders (MSDs) with physicians prescribing homeopathic and other complementary medicine? Results from the EPI3-LASER survey in France

  • 1. RESEARCH ARTICLE Open Access Who seeks primary care for musculoskeletal disorders (MSDs) with physicians prescribing homeopathic and other complementary medicine? Results from the EPI3-LASER survey in France Michel Rossignol1* , Bernard BĂ©gaud2 , Bernard Avouac3 , France Lert4 , FrĂ©dĂ©ric Rouillon5 , Jacques BĂ©nichou6 , Jacques Massol7 , GĂ©rard Duru8 , Anne-Marie Magnier9 , Didier Guillemot10 , Lamiae Grimaldi-Bensouda11 , Lucien Abenhaim12 Abstract Background: There is a paucity of information describing patients with musculoskeletal disorders (MSDs) using complementary and alternative medicines (CAMs) and almost none distinguishing homeopathy from other CAMs. The objective of this study was to describe and compare patients with MSDs who consulted primary care physicians, either certified homeopaths (Ho) or regular prescribers of CAMs in a mixed practice (Mx), to those consulting physicians who strictly practice conventional medicine (CM), with regard to the severity of their MSD expressed as chronicity, co-morbidity and quality of life (QOL). Methods: The EPI3-LASER study was a nationwide observational survey of a representative sample of general practitioners and their patients in France. The sampling strategy ensured a sufficient number of GPs in each of the three groups to allow comparison of their patients. Patients completed a questionnaire on socio-demographics, lifestyle and QOL using the Short Form 12 (SF-12) questionnaire. Chronicity of MSDs was defined as more than twelve weeks duration of the current episode. Diagnoses and co-morbidities were recorded by the physician. Results: A total of 825 GPs included 1,692 MSD patients (predominantly back pain and osteoarthritis) were included, 21.6% in the CM group, 32.4% Ho and 45.9% Mx. Patients in the Ho group had more often a chronic MSD (62.1%) than the CM (48.6%) or Mx (50.3%) groups, a result that was statistically significant after controlling for patients’ characteristics (Odds ratio = 1.43; 95% confidence interval (CI): 1.07 - 1.89). Patients seen by homeopaths or mixed practice physicians who were not the regular treating physician, had more often a chronic MSD than those seen in conventional medicine (Odds ratios were1.75; 95% CI: 1.22 - 2.50 and 1.48; 95% CI: 1.06 - 2.12, respectively). Otherwise patients in the three groups did not differ for co-morbidities and QOL. Conclusion: MSD patients consulting primary care physicians who prescribed homeopathy and CAMs differed from those seen in conventional medicine. Chronic MSD patients represented a greater proportion of the clientele in physicians offering alternatives to conventional medicine. In addition, these physicians treated chronic patients as consulting rather than regular treating physicians, with potentially important impacts upon professional health care practices and organisation. * Correspondence: Michel.Rossignol@CRR-Intl.com 1 Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada and LA-SER Centre for Risk Research, Montreal, Canada Full list of author information is available at the end of the article Rossignol et al. BMC Musculoskeletal Disorders 2011, 12:21 http://www.biomedcentral.com/1471-2474/12/21 © 2011 Rossignol et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 2. Background Physicians in primary care play a central role in the man- agement of musculoskeletal disorders (MSDs). This group of health problems also represents a leading reason of recourse to complementary and alternative medicines (CAM) including homeopathy. There is a paucity of information describing MSD patients using CAMs and almost none distinguishing homeopathy from other forms of CAM. In France, homeopathy is the most fre- quently used CAM and is prescribed only by physicians, typically general practitioners (GP). In addition, homeop- athy is reimbursed by the French National Health Insur- ance which allowed a fair comparison of patients who seek care with physicians who prescribe and don’t pre- scribe homeopathy and CAMs. The objective of this study was to describe and compare patients with MSDs consulting primary care physicians, either certified homeopaths (Ho) or regular prescribers of CAMS in a mixed practice (Mx), to those consulting physicians who practice strictly conventional medicine (CM), with regard to the severity of their MSD expressed as chronicity, co-morbidity and quality of life (QOL). Methods Study design and population This analysis used data collected from the EPI3-LASER nationwide observational survey of a representative sam- ple of general practitioners and their patients, conducted in France between March 2007 and July 2008. Its aims were to assess the burden of disease in general practice, considering physician and patients characteristics and co-morbidities with a specific focus on health-related QOL. Study subjects were drawn from a two-stage sam- pling. First, general practitioners (GPs) were randomly selected from the French national directory of physicians and invited to participate. GPs sampling was stratified according to their declaration of CAM utilisation cate- gorised in three groups, strict conventional medicine practitioners (CM) who declared themselves never or rarely using homeopathy or CAMs, physicians declaring using CAMs regularly in a mixed practice (Mx), and registered homeopaths who are GPs specialised in homeopathy (Ho). Physicians were classified in one of those three categories after they had agreed to partici- pate to the survey by answering a short telephone ques- tionnaire designed to that effect. As physicians in all three groups were certified professionals, their practice was based on conventional medicine. The Ho group dif- fered because the physicians were also certified homeo- paths with a clear orientation toward this type of CAM. The Mx group however could not be labelled specifically as they only declared their use of CAMs but did not indicate the type or any specific preferences. Sampling of physicians continued until Mx and Ho GPs were over-sampled compared to CM GPs with ratios respectively of 2:1 and 3:2. This was done in order to account for the variety of practices, especially in the Mx group. The second stage of sampling con- sisted of randomly selecting a one-day of consultation for each participating physician to survey all patients attending the practice on that specific day. All patients were eligible for inclusion at the exception of those whose health status or literacy level did not allow responding to a self-administered questionnaire. Data collection Consenting patients completed a self-administered ques- tionnaire that included information on age, sex, educa- tion, employment status and occupation, hospitalisation and medical visits in the previous twelve months, smok- ing, alcohol intake, physical activity, height and weight, and health related QOL assessed by the Short Form 12 (SF-12) questionnaire [1]. Patients were also asked to declare if the physician consulted that day was their reg- ular treating physician or not. In France all citizens are required to identify a physician for their regular health care. In this study, the physicians’ role was labelled ‘treating’ or ‘consulting’ based on patients’ responses. GPs completed a medical questionnaire including the main reason for consultation and up to five other diag- noses present that day and for each, the duration of the health problem in its current episode. GPs then recorded their prescriptions that day for diagnostic tests, drugs and referrals. Diagnoses were coded by a trained archivist using the 9th revision of the International Clas- sification of Diseases. for this analysis, adult patients 18 years and older with a MSD as their main reason for consultation, were selected from the general survey. MSDs included spinal disorders (SD) with ICD codes 720 to 724, osteoarthritis and tendonitis of the upper or lower limb, with ICD codes 715, 719, 729, 726-728, 782. Patients with a diagnosis of infectious, neoplastic or specific inflammatory (such as rheumatoid arthritis or Lupus) joint disease as their main reason for consulta- tion were excluded from the analyses. MSDs were clas- sified as non-chronic or chronic using a twelve-week (three months) cut-off for duration of symptoms at inclusion in accordance with consensus recommenda- tions for research on MSDs [2]. Co-morbidity was defined as the presence of at least one diagnosis other than the principal reason of consultation at the recruit- ment visit. Co-morbidities were categorised as MSD (other than the main reason for consultation), cardio- vascular or respiratory, anxiety or depressive disorders, sleeping disorders and digestive. Rossignol et al. BMC Musculoskeletal Disorders 2011, 12:21 http://www.biomedcentral.com/1471-2474/12/21 Page 2 of 6
  • 3. Statistical analysis Patient non-participation was accounted for by perform- ing a calibration of the sample using the CALMAR pro- cedure on all variables that were collected from all eligible patients (sex, age, length of time attending the GPs’ practice, type of health insurance and main reason for consultation) [3]. Multiple logistic regression ana- lyses were used to compare patients in the Ho and Mx groups to the CM group for categorical variables and adjusted for all variables in Table 1 and 2 for potential confounding. Mean scores of the SF-12 mental and physical scales were adjusted for sex, age and co-mor- bidities using the analysis of covariance. All analyses were performed using SAS version 9.1. The study was approved by the French National Data- Protection Commission (CNIL) and the French National Council of Physicians (CNOM). Participating physicians received compensation fees for recruiting but not patients. Results Patients’ characteristics Eight hundred and twenty five physicians agreed to par- ticipate in the study. Their geographical distribution covered the 22 regions of France. Their median age was 52 years, 20% were female, 52% worked in solo practice and 78% practiced fee-for-service in addition to the gen- eral health insurance regime which corresponds to national statistics on medical manpower [4]. Of the 10,803 patients identified as potential participants, 2,151 (20%) declined participation and 93 were excluded because of missing information leaving a final sample of 8,559, of whom 1,692 (20%) had a MSD. Characteristics of patients by type of medical practice are shown in Table 1. Patients in the Ho group were more often older non-smoking females with higher education and a lower body mass index than in the CM group. Patients in the Mx group did not differ from those in the CM group. Type and severity of MSDs Characteristics of MSDs by type of primary care practice are shown in Table 2. The mix of spinal (low-back pain and other back problems) and non-spinal MSDs was similar between groups with spinal representing over one third of the reasons for consultation. The first indicator of severity of MSD, chronicity, was more often observed in homeopathic practice, with 62.1% lasting for more than twelve weeks at the time of the survey, versus 48.6% in the CM group, a difference which was statistically significant in multivariate analysis with an Odds ratio of 1.43 (95% confidence interval (CI): 1.07 - 1.89). At the same time, homeopaths were less often declared as the regular treating physician by their patients with 54.1% compared with 84.0% in the CM practice group. An interaction was observed between chronicity of the MSD and not being the regu- lar treating physician (consulting). An excess risk of chronicity of 75% and 48% respectively was observed in MSD patients in the Ho and Mx groups when the physi- cian was a consultant compared to being the regular treating physician (Odds ratios respectively 1.75, (95% CI : 1.22 - 2.50 and 1.48, 95%CI: 1.06 - 2.12). The second indicator of severity of MSD was the fre- quency of co-morbidities (Table 3). Proportions of Table 1 Socio-demographic characteristics of patients consulting for a MSD in primary care (N = 1692) Type of primary care provider Conventional medicine Mixed Homeopathic N = 366 N = 778 N = 548 Sex (% Females) 59.0 64.2 76.9* Age categories 18-39 21.7 19.6 13.9* 40-59 35.8 39.2 37.3* 60 and over 42.4 41.2 48.8* Employment status (%) Employed 47.5 44.9 42.7 Unemployed 2.6 4.3 2.0 Home maker 2.9 5.1 3.2 Student 2.4 1.5 1.5 Retired 44.6 44.1 50.5 Educational level (%) Secondary school or more 39.4 35.4 45.9* Familial status (%) Living with a spouse 66.7 67.7 68.8 Living with children 36.8 40.3 36.4 Body Mass Index <25 46.3 48.8 59.1* 25-30 36.9 32.8 31.1* 30 and over 16.8 18.5 9.6* Tobacco consumption (%) Non smoker 48.1 55.5 62.1* Past smoker 25.7 24.1 23.1* Current smoker 26.2 20.4 14.7* Alcohol Consumption (%) Never 33.1 32.6 28.8 Sometimes 51.4 55.4 57.4 Daily 15.5 12.0 13.8 Physical exercise (%) 0-30 minutes per day 59.5 60.9 66.1 31 minutes and over 40.5 39.1 33.9 * Difference with conventional medicine category statistically significant (p ≀ 0.05) in logistic regression including all variables. Rossignol et al. BMC Musculoskeletal Disorders 2011, 12:21 http://www.biomedcentral.com/1471-2474/12/21 Page 3 of 6
  • 4. patients with any type of co-morbidities were very simi- lar between the three groups of patients. MSDs as sec- ondary diagnoses (in addition the MSD main diagnosis) were relatively frequent with 13.1% to 15.7% across the three groups of patients. Similar proportions were observed for anxiety and depressive disorders (12.5% to 14.6%). Sleeping and digestive disorders were less fre- quent co-morbidities and did not show important differ- ences between types of physicians’ practice. Thirdly, severity of MSD was assessed with the SF-12 instrument, a standardised measure of QOL. The mean scores adjusted for age, sex, co-morbidities and whether the treating physician was the regular physician or not, showed no difference between the types of practices, the mental and physical SF-12 scores being almost identical (Table 4). Comparisons between chronic and non- chronic patients however showed lower SF-12 values indicating poorer QOL in chronic patients in the CM or Mx practice groups but not in the Ho group. Discussion This study is one of few providing comparative data on use of homeopathy and other types of CAMs compared to conventional primary care in a representative popula- tion of patients. The results showed that patients who consult for MSDs were comparable for quality of life and co-morbidities regardless of the physicians’ prefer- ences for prescribing homeopathy or CAMs. This corre- sponds to what has been reported for physical QOL score but not for mental score where patients using CAMs have been found to have a slightly lower mental scores [5-9]. Our study also showed that patients with chronic MSDs tended to seek care more often with GPs who prescribe alternatives to conventional medicine, a finding that has been reported in other studies [10,11]. Socio-demographic and lifestyle differences between MSD patients in the three groups of physicians could have contributed in part to the results. For instance, patients consulting homeopaths were more often older and more educated women with less lifestyle risk factors than those consulting in conventional primary care. This corresponds to what has been described in other studies of consultations in homeopathy in general [12-15]. However, these factors were controlled for in the analyses and the magnitude of the difference with regard to chronicity was too high to be explained by confounding factors alone. We also found that these chronic MSD patients more often declared their physician as not being their regular treating physician. In France each citizen is required to identify a physician for their regular health care. There- fore, patients who did not declare their physician as their regular physician, could be considered as consult- ing in second intention, outside of their regular primary care provider. The greater health care load assumed by physicians who prescribe homeopathy and CAMs then comes from two factors, greater proportions of chronic patients and consultations in second intention. This finding has significant bearing on professional practice as almost half of the homeopath clientele in this study was seen as a consultant. This information provided an important complement to what has been reported on the planning of homeopathic practice, particularly as it differs from conventional medicine [16]. One strength of the study was that MSD patients were identified from a larger survey of patients consulting for Table 2 Characteristics of musculoskeletal disorders (MSD) in three types of primary care practice (N = 1,692) Type of primary care practice Conventional Medicine Mixed Homeopathic (N = 366) (N = 778) (N = 548) MSD site (%) Spinal 37.7 41.2 35.9 Non-spinal 62.3 58.8 64.1 Chronicity (%) >12 weeks 48.6 50.3 62.1 Physician role1 (%) Treating 84.0 81.8 54.1 Consulting 16.0 18.2 45.9 Adjusted Odds ratios2 Risk of chronicity (vs. conventional medicine) 1 (–) 0.98 (0.77 - 1.26) 1.43 (1.07 - 1.89) Risk of chronicity when Consulting (vs. Treating) 1.12 (0.63 - 1.99) 1.48 (1.06 - 2.12) 1.75 (1.22 - 2.50) 1. Role of the physician as declared by the patient; in France every citizen has to choose a physician as their regular treating physician (treating), physicians who are not the regular treating physician are called here consulting physicians. 2. Logistic regression models controlling for all variables in Table 1 and 2. Rossignol et al. BMC Musculoskeletal Disorders 2011, 12:21 http://www.biomedcentral.com/1471-2474/12/21 Page 4 of 6
  • 5. any reason in primary care, thus minimising selection bias related to sampling MSD patients directly. Another strength was the specificity of the data collection for the purposes of this study, combining medical information on diagnoses and patients’ information on QOL, drugs and CAMs utilisation, all collected on the day of con- sultation, ensuring timely compatibility with diagnoses. The large number of participating physicians and patients favoured a fair representativity of clinical prac- tices in primary care in France. A previous analysis of the EPI3-LASER survey showed that the distribution of physicians’ individual characteristics differed only slightly from published French national statistics [4]. SF-12 scores observed in our patients were also not far away from those reported in three European population surveys of MSD patients, with score differences between acute and chronic patients that were also similar [17,18]. The main limitation of this study was the way the three groups of physicians were defined, relying on their own declaration of prescribing CAMs never or rarely (CM) or regularly (Mx). The definition used for defining the group of homeopaths (Ho) was more straightfor- ward, being based on their professional certification. These definitions potentially limit the generalisation of the results as they represent the practice in France. On the other hand, it also represents a strength because it provided a unique opportunity to compare head-to-head primary care practices differing only by preferences for homeopathy and CAMs, all physicians shared similar medical professional status and basic training in conven- tional medicine. We feel that even if the context of the study was specific to one country, differences between the groups of patients may provide valid information on the differential utilisation of homeopathy and CAMs, meaningful beyond national borders. Another important difference with studies performed in other countries is that France is unique with Ger- many to reimburse homeopathy in a national health insurance regime. Therefore, access to this type of medi- cal practice is specific and, unlike what has been reported in the literature, less subjected to economic barriers [13]. The best illustration of this came from our observation of no apparent differences of access to homeopathy and CAM by employment status. The eco- nomic impacts of homeopathy and CAM on health care deserve more attention in future research, particularly in terms of the cost-benefit of complementary approaches for chronic MSD patients who seek alternatives to con- ventional medicine for the relief of their symptoms. Table 3 Co-morbidities in patients with musculoskeletal disorders (MSD) in three types of primary care practice (N = 1,692) Type of primary care practice Co-morbidities present at the medical visit Conventional Medicine Mixed Homeopathic N = 366 N = 778 N = 548 At least one MSD co-morbidity (%) 13.8 13.1 15.7 At least one other co-morbidity (%) 72.7 73.3 74.4 Cardiovascular or respiratory conditions 29.9 31.6 28.1 Anxiety or depressive disorders 14.5 12.5 14.6 Sleeping disorders 4.3 3.5 4.6 Digestive disorders 8.0 6.7 8.1 Table 4 Quality of life in patients with musculoskeletal disorders (MSD) in three types of primary care practice (N = 1,692) Type of primary care practice Conventional Medicine Mixed Homeopathic All Acute1 Chronic1 All Acute Chronic All Acute Chronic Quality of life SF-12 Mental score2 41.7 43.2* 40.0* 42.0 42.9* 41.1* 41.7 41.2 42.0 Mean (SD) (10.7) (9.5) (11.5) (10.3) (10.4) (10.1) (9.6) (9.3) (9.7) Physical score2 42.4 43.4 41.3 41.9 43.1* 40.7* 42.8 43.6 42.3 Mean (SD) (10.4) (10.3) (10.4) (10.4) (10.9) (9.8) (10.8) (10.1) (11.2) 1 Chronicity defined as duration of the current MSD episode for more than 12 weeks. 2 Adjusted means in covariance analyses including age, sex, presence of co-morbidities and regular treating physician or not. * Differences between acute and chronic patients statistically significant at p < 0.05. Rossignol et al. BMC Musculoskeletal Disorders 2011, 12:21 http://www.biomedcentral.com/1471-2474/12/21 Page 5 of 6
  • 6. Conclusion MSD patients consulting a primary care physician who prescribed homeopathy and CAMs differed from those seen in conventional medicine. Accounting for the socio-demographic and lifestyle differences, chronic MSD patients represented a greater proportion of the clientele in physicians offering alternatives to conven- tional medicine. In addition, they treated chronic patients as consulting rather than regular treating physi- cians, with potentially important impacts upon profes- sional health care practices and organisation. Acknowledgements The study was sponsored by an unrestricted funding from Laboratoires Boiron, France to the members of LA-SER. Lamiae Bensouda-Grimaldi was the recipient of a research fellowship from INSERM (French National Institute of Health and Medical Research) at the time of the study. The authors wish to thank Djamila Abed and RĂ©mi Sitta for their technical contribution in data analyses. Author details 1 Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada and LA-SER Centre for Risk Research, Montreal, Canada. 2 INSERM U657, UniversitĂ© Bordeaux2, Bordeaux, France. 3 LA-SER, Paris, France. 4 INSERM, Centre for Epidemiology and Population Health, Villejuif, France. 5 Centre Hospitalier Sainte-Anne, UniversitĂ© Paris V RenĂ© Descartes, Paris, France. 6 INSERM U657 Pharmacoepidemiology and evaluation of the impact of health products on human health, France, and Department of Biostatistics, University Hospital of Rouen, Rouen, France. 7 UFR de MĂ©decine, UniversitĂ© de Franche ComtĂ©, Besançon, France. 8 CNRS (French National Center for Scientific Research), UniversitĂ© Claude Bernard, Lyon, France. 9 FacultĂ© de mĂ©decine UniversitĂ© Pierre et Marie Curie, Paris, France. 10 Institut Pasteur and UniversitĂ© Paris-Ile de France Ouest, Paris, France. 11 Equipe d’acceuil PharmacoĂ©pidĂ©miologie et maladies infectieuses, Institut Pasteur, and LA-SER, Paris Cochin santĂ©, France. 12 Department of Epidemiology, London School of Hygiene & Tropical Medicine, London, U.K., and LA-SER, London, U.K. Authors’ contributions All authors are members of the scientific committee that developed and approved the study protocol and the analyses plan, discussed and interpreted the results and revised the manuscript. MR, FL and LA drafted the manuscript, LBG supervised all operational aspects of the study including recruitments, data collection and management. MR supervised data analyses. All authors have read and approved the final manuscript. Competing interests The authors declare that they have no competing interests. Received: 16 August 2010 Accepted: 19 January 2011 Published: 19 January 2011 References 1. Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233. 2. Dionne CE, Dunn KM, Croft PR, Nachemson AL, Buchbinder R, Walker BF, Wyatt M, Cassidy JD, Rossignol M, Leboeuf-Yde C, Hartvigsen J, Leino- Arjas P, Latza U, Reis S, Gil Del Real MT, Kovacs FM, Oberg B, Cedraschi C, Bouter LM, Koes BW, Picavet HS, van Tulder MW, Burton K, Foster NE, Macfarlane GJ, Thomas E, Underwood M, Waddell G, Shekelle P, Volinn E, Von Korff M: A consensus approach toward the standardization of back pain definitions for use in prevalence studies. Spine 2008, 33:95-103. 3. Deville JC, SĂ€rndal CE: Calibration estimation in survey sampling. J Am Stat Assoc 1992, 87:375-382. 4. Institut de recherche et documentation en Ă©conomie de la santĂ© (IRDES). DĂ©mographie des mĂ©decins Paris, France : IRDES; 2008. 5. Artus M, Croft P, Lewis M: The use of CAM and conventional treatments among primary care consulters with chronic musculoskeletal pain. BMC Fam Pract 2007, 8:26. 6. Chenot JF, Becker A, Leonhardt C, Keller S, Donner-Banzhoff N, Baum E, Pfingsten M, Hildebrandt J, Basler HD, Kochen MM: Use of complementary alternative medicine for low back pain consulting in general practice: a cohort study. BMC Complement Altern Med 2007, 7:42. 7. Cizmesija T, Bergman-Marković B: [Use of complementary and alternative medicine among the patients in primary health care]. Acta Med Croatica 2008, 62:15-22. 8. Herman CJ, Allen P, Hunt WC, Prasad A, Brady TJ: Use of complementary therapies among primary care clinic patients with arthritis. Prev Chronic Dis 2004, 1:A12. 9. Lind BK, Lafferty WE, Tyree PT, Sherman KJ, Deyo RA, Cherkin DC: The role of alternative medical providers for the outpatient treatment of insured patients with back pain. Spine 2005, 30:1454-1459. 10. Boon HS, Cherkin DC, Erro J, Sherman KJ, Milliman B, Booker J, Cramer EH, Smith MJ, Deyo RA, Eisenberg DM: Practice patterns of naturopathic physicians: results from a random survey of licensed practitioners in two US States. BMC Complement Altern Med 2004, 4:14. 11. Steinsbekk A, Adams J, Sibbritt D, Jacobsen G, Johnsen R: The profiles of adults who consult alternative health practitioners and/or general practitioners. Scand J Prim Health Care 2007, 25:86-92. 12. Cherkin DC, Deyo RA, Sherman KJ, Hart LG, Street JH, Hrbek A, Davis RB, Cramer E, Milliman B, Booker J, Mootz R, Barassi J, Kahn JR, Kaptchuk TJ, Eisenberg DM: Characteristics of visits to licensed acupuncturists, chiropractors, massage therapists, and naturopathic physicians. J Am Board Fam Pract 2002, 15:463-472. 13. Fleming S, Rabago DP, Mundt MP, Fleming MF: CAM therapies among primary care patients using opioid therapy for chronic pain. BMC Complement. Altern Med 2007, 7:15. 14. Herman CJ, Dente JM, Allen P, Hunt WC: Ethnic differences in the use of complementary and alternative therapies among adults with osteoarthritis. Prev Chronic Dis 2006, 3:A80. 15. Kikuchi M, Matsuura K, Matsumoto Y, Inagaki T, Ueda R: Bibliographical investigation of complementary alternative medicines for osteoarthritis and rheumatoid arthritis. Geriatr Gerontol Int 2009, 9:29-40. 16. Thompson EA, Mathie RT, Baitson ES, Barron SJ, Berkovitz SR, Brands M, Fisher P, Kirby TM, Leckridge RW, Mercer SW, Nielsen HJ, Ratsey DH, Reilly D, Roniger H, Whitmarsh TE: Towards standard setting for patient- reported outcomes in the NHS homeopathic hospitals. Homeopathy 2008, 97:114-121. 17. Kadam UT, Schellevis FG, Lewis M, van der Windt DA, de Vet HC, Bouter LM, Croft PR: Does age modify the relationship between morbidity severity and physical health in English and Dutch family practice populations? Qual Life Res 2009, 18:209-220. 18. Loza E, Jover JA, Rodriguez L, Carmona L, EPISER Study Group: Multimorbidity: prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease. Semin Arthritis Rheum 2009, 38:312-319. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2474/12/21/prepub doi:10.1186/1471-2474-12-21 Cite this article as: Rossignol et al.: Who seeks primary care for musculoskeletal disorders (MSDs) with physicians prescribing homeopathic and other complementary medicine? Results from the EPI3-LASER survey in France. BMC Musculoskeletal Disorders 2011 12:21. Rossignol et al. BMC Musculoskeletal Disorders 2011, 12:21 http://www.biomedcentral.com/1471-2474/12/21 Page 6 of 6